← Back to All Filings

Equillium COO Sells $47k in Stock Under Pre-Arranged Trading Plan

Low SignificanceDecember 15, 2025 at 6:03:59 PM EST

Equillium, Inc.

$EQ4CIK: 0001746466

Subscribe to track EQ

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Equillium COO Sells $47k in Stock Under Pre-Arranged Trading Plan

Company: Equillium, Inc. (EQ) Form: 4 | Filed: 2025-12-15 Significance: Low

Insider: Zedelmayer Christine Title: Sr. Vice President and COO | Relationship: Officer

Transaction: • Type: Sale (Aggregated) • Shares: 35,704 • Avg. Price: $1.33 • Value: $47,466 • Owned After: 91,444

Key Insight: The sale was conducted under a pre-scheduled Rule 10b5-1 trading plan, reducing its significance as a market signal. The total value is minor relative to the company's market cap.

Market Context: The transaction represents approximately 0.08% of Equillium's $60 million market capitalization.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Equillium, Inc. (EQ)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Senior Vice President and COO of Equillium, Inc. sold shares worth approximately $47,466 under a pre-arranged 10b5-1 trading plan.
  • Market Impact: The transaction's value is negligible compared to the company's market capitalization, suggesting a minimal market impact.

Company Information

FieldValue
CompanyEquillium, Inc.
Ticker SymbolEQ
CIK0001746466
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameZedelmayer Christine
CIK0001797818
Title/PositionSr. Vice President and COO
RelationshipOfficer

Transaction Details

This filing reports two separate sale transactions. The details below are aggregated.

FieldValue
Form Type4
Transaction Date2025-12-12 to 2025-12-15
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved35,704
Avg. Price Per Share$1.33
Total Value$47,466.36
Shares Owned After91,444
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$47,466.36
% of Market Cap0.08%
Shares Transacted35,704
% of Shares OutstandingNot Available
Post-Transaction Ownership91,444 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $60 million, the $47k sale is financially immaterial, representing less than 0.1% of the company's value.
  • Ownership Concentration: The insider sold approximately 28% of her holdings reported in this filing. While a notable percentage of her personal stake, the absolute value is small.
  • Transaction Significance: The transaction is rated as having low significance due to its small value relative to the company's market cap and its execution under a pre-scheduled 10b5-1 plan, which decouples it from immediate corporate developments.

Additional Context

Special Circumstances

  • The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by the insider on August 27, 2025. Such plans are established in advance to automatically execute trades, mitigating accusations of trading on non-public information.
Topics:#SECFiling#InsiderTrading#Form4#InsiderSell#EQ#Equillium#StockMarket#Biotech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.